Abstract
Objective: To investigate the effect of 8-week whole body vibration training on gait performance and lower extremity function in stroke patients with knee hyperextension.
Methods: Total 30 subjects with stroke were randomized into the control group (n=15) or the intervention group (n=15). The patients of intervention group were treated with whole body vibration while the control group was treated with placebo. The walking function, lower limb function and knee hyperextension times were assessed in this study. Gait performances were evaluated by 10-meter walk test. The knee hyperextension times was visually observed and counted. The lower limb function was evaluated by Fugl-Meyer motor assessment.
Results: The times of the knee hyperextension of the intervention group was significantly decreased compared with control groups (P=0.000, d=1.749, 95%CI[2.915,7.285]). The walking function assessed by 10-meter test of intervention group was significantly improved compared with control group (P=0.001, d=1.345, 95%CI[1.896,6.704]). The performances of all the three tests were improved after training in both groups (P=0.000/P=0.000, d=1.500/d=1.952, 95%CI[3.309,9.891]/ 95%CI[5.549,12.45]; P=0.000/P=0.000, d=2.015/d=2.952, 95%CI[5.214,11.39]/95%CI[9.423, 15.98]; P=0.000/P=0.000, d=3.537/d=5.108, 95%CI[19.05,12.35]/95%CI[16.52,22.28]).
Conclusion: The results suggest that 8 weeks whole body vibration training can reduce knee hyperextension and increase ambulatory speed in stroke patients.
Keywords: Stroke, knee hyperextension, whole body vibration training, lower extremity function.
CNS & Neurological Disorders - Drug Targets
Title:Whole body vibration training improves walking performance of stroke patients with knee hyperextension: a randomized controlled pilot study
Volume: 14 Issue: 9
Author(s): Chuan Guo, Xun Mi, Shouguo Liu, Wenchao Yi, Chen Gong, Lan Zhu, Sergio Machado, Ti-Fei Yuan and Chunlei Shan
Affiliation:
Keywords: Stroke, knee hyperextension, whole body vibration training, lower extremity function.
Abstract: Objective: To investigate the effect of 8-week whole body vibration training on gait performance and lower extremity function in stroke patients with knee hyperextension.
Methods: Total 30 subjects with stroke were randomized into the control group (n=15) or the intervention group (n=15). The patients of intervention group were treated with whole body vibration while the control group was treated with placebo. The walking function, lower limb function and knee hyperextension times were assessed in this study. Gait performances were evaluated by 10-meter walk test. The knee hyperextension times was visually observed and counted. The lower limb function was evaluated by Fugl-Meyer motor assessment.
Results: The times of the knee hyperextension of the intervention group was significantly decreased compared with control groups (P=0.000, d=1.749, 95%CI[2.915,7.285]). The walking function assessed by 10-meter test of intervention group was significantly improved compared with control group (P=0.001, d=1.345, 95%CI[1.896,6.704]). The performances of all the three tests were improved after training in both groups (P=0.000/P=0.000, d=1.500/d=1.952, 95%CI[3.309,9.891]/ 95%CI[5.549,12.45]; P=0.000/P=0.000, d=2.015/d=2.952, 95%CI[5.214,11.39]/95%CI[9.423, 15.98]; P=0.000/P=0.000, d=3.537/d=5.108, 95%CI[19.05,12.35]/95%CI[16.52,22.28]).
Conclusion: The results suggest that 8 weeks whole body vibration training can reduce knee hyperextension and increase ambulatory speed in stroke patients.
Export Options
About this article
Cite this article as:
Guo Chuan, Mi Xun, Liu Shouguo, Yi Wenchao, Gong Chen, Zhu Lan, Machado Sergio, Yuan Ti-Fei and Shan Chunlei, Whole body vibration training improves walking performance of stroke patients with knee hyperextension: a randomized controlled pilot study, CNS & Neurological Disorders - Drug Targets 2015; 14 (9) . https://dx.doi.org/10.2174/1871527315666151111124937
DOI https://dx.doi.org/10.2174/1871527315666151111124937 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
Techniques of Drug Repurposing: Delivering a new life to Herbs & Drugs
Of late, with the adaptation of innovative approaches and integration of advancements made towards medical sciences as well as the availability of a wide range of tools; several therapeutic challenges are being translated into viable clinical solutions, with a high degree of efficacy, safety, and selectivity. With a better understanding ...read more
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Investigation of Anticholinesterase Activity of a Series of Salvia Extracts and the Constituents of Salvia staminea
The Natural Products Journal Comparison of Triflusal with Aspirin in the Secondary Prevention of Atherothrombotic Events; Α Randomised Clinical Trial
Current Vascular Pharmacology Kawasaki Disease and Its Treatment – An Update
Current Rheumatology Reviews Oral Lipid Based Drug Delivery System (LBDDS): Formulation, Characterization and Application: A Review
Current Drug Delivery Hyperhomocysteinaemia: A Critical Review of Old and New Aspects
Current Drug Metabolism CGRP-Receptor Antagonism in Migraine Treatment
CNS & Neurological Disorders - Drug Targets Vascular Disease and Risk Factors in Chronic Kidney Disease
Vascular Disease Prevention (Discontinued) Synthesis, Characterization and Physico-chemical Properties of New 2-(4- Arylpiperazine-1-yl)-1-(3-methylbenzofuran-2-yl)ethanoles as Potential Antihypertensive Agents
Current Organic Chemistry ApoE ε4 Allele Related Alterations in Hippocampal Connectivity in Early Alzheimer’s Disease Support Memory Performance
Current Alzheimer Research Non Invasive Indexes for the Assessment of Patients with Non-alcoholic Fatty Liver Disease
Current Pharmaceutical Design Markers of Systemic Inflammation in Obstructive Sleep Apnea Syndrome
Current Respiratory Medicine Reviews UGT1A1 Mediated Drug Interactions and its Clinical Relevance
Current Drug Metabolism Nocturnal Blood Pressure Abnormalities in Obstructive Sleep Apnea - Clinical Predictors
Current Respiratory Medicine Reviews Geriatric Psychopharmacology in Acute Settings
Current Psychopharmacology Meet Our Editorial Board Members:
Current Genomics Under the Microscope: Focus on Chlamydia pneumoniae Infection and Multiple Sclerosis
Current Neurovascular Research NOAC in Acute Coronary Syndrome and AF?
Cardiovascular & Hematological Disorders-Drug Targets Dyslipidemia, Metabolic Syndrome and Vascular Disease Among Asian Indians
Vascular Disease Prevention (Discontinued) Regulation of Endothelial Nitric Oxide Synthase in Pathophysiological Conditions
Cardiovascular & Hematological Disorders-Drug Targets Curcumin Suppresses Tumor Growth and Angiogenesis in Human Glioma Cells Through Modulation of Vascular Endothelial Growth Factor/ Angiopoietin-2/Thrombospondin-1 Signaling
CNS & Neurological Disorders - Drug Targets